These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 8920903)
1. The c-Mos proto-oncogene product stimulates c-Jun transcriptional activity by a MAP kinase-dependent mechanism. Sever R; Turner R Biochem Biophys Res Commun; 1996 Nov; 228(2):259-66. PubMed ID: 8920903 [TBL] [Abstract][Full Text] [Related]
2. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene. Ainbinder E; Bergelson S; Daniel V Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828 [TBL] [Abstract][Full Text] [Related]
3. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation. Cruzalegui FH; Hardingham GE; Bading H EMBO J; 1999 Mar; 18(5):1335-44. PubMed ID: 10064599 [TBL] [Abstract][Full Text] [Related]
4. JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. Weiss C; Schneider S; Wagner EF; Zhang X; Seto E; Bohmann D EMBO J; 2003 Jul; 22(14):3686-95. PubMed ID: 12853483 [TBL] [Abstract][Full Text] [Related]
5. Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos. Pham CD; Vuyyuru VB; Yang Y; Bai W; Singh B Oncogene; 1999 Jul; 18(30):4287-94. PubMed ID: 10439036 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of c-jun mediated by MAP kinases. Pulverer BJ; Kyriakis JM; Avruch J; Nikolakaki E; Woodgett JR Nature; 1991 Oct; 353(6345):670-4. PubMed ID: 1922387 [TBL] [Abstract][Full Text] [Related]
7. Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding. Fukasawa K; Zhou R; Matten WT; Armstrong AJ; Daar I; Oskarsson M; Sathyanarayana BK; Maclvor L; Wood TG; Vande Woude GF Oncogene; 1995 Oct; 11(8):1447-57. PubMed ID: 7478569 [TBL] [Abstract][Full Text] [Related]
8. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product. Schönthal A; Feramisco JR New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599 [TBL] [Abstract][Full Text] [Related]
9. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034 [TBL] [Abstract][Full Text] [Related]
10. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
11. Kinase activities of c-Mos and v-Mos proteins: a single amino acid exchange is responsible for constitutive activation of the 124 v-Mos kinase. Puls A; Proikas-Cezanne T; Marquardt B; Propst F; Stabel S Oncogene; 1995 Feb; 10(4):623-30. PubMed ID: 7862439 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786 [TBL] [Abstract][Full Text] [Related]
16. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817 [TBL] [Abstract][Full Text] [Related]
17. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases. Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217 [TBL] [Abstract][Full Text] [Related]
18. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells. Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes. Chesnel F; Bonnec G; Tardivel A; Boujard D Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517 [TBL] [Abstract][Full Text] [Related]
20. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Natoli G; Avantaggiati ML; Chirillo P; Puri PL; Ianni A; Balsano C; Levrero M Oncogene; 1994 Oct; 9(10):2837-43. PubMed ID: 8084589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]